Combined hypothyroidism and hypoparathyroidism in an infant after maternal 131I administration.
D002277:Carcinoma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006996:Hypocalcemia / Q000209:etiology; D007011:Hypoparathyroidism / Q000139:chemically induced*; D007037:Hypothyroidism / Q000139:chemically induced* / Q000188:drug therapy; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000139:chemically induced*; D007457:Iodine Radioisotopes / Q000009:adverse effects* / Q000627:therapeutic use; D008431:Maternal-Fetal Exchange; D010634:Phenobarbital / Q000627:therapeutic use; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D013964:Thyroid Neoplasms / Q000188:drug therapy*; D013974:Thyroxine / Q000627:therapeutic use; D014132:Trachea / Q000601:surgery; D014140:Tracheotomy / Q000009:adverse effects
D007457:Iodine Radioisotopes; D013974:Thyroxine; D010634:Phenobarbital